Mar. 24, 2023
GLPG2534: What Happened to IRAK4? A Galapagos Case Study
GLPG2534
oral IRAK4 inhibitor promising activity in mouse model for atopic dermatitis HTS of kinase-focused 25K cmpd libraryvs. IRAK4 catalytic domain Sci. Trans. Med., February 15, 2023 Galapagos, FR + BE